Loading...
A phase I/II dose finding study evaluating the safety and tolerability of capecitabine and aflibercept in patients with unresectable metastatic colorectal cancer deemed unsuitable for doublet/triplet chemotherapy: results of the phase I study
Ross, P Repana, D Saunders, Mark P Wilson, R Plummer, C Summers, J Higgins, F Peacock, J Harari, D Bridgewater, J
Ross, P
Repana, D
Saunders, Mark P
Wilson, R
Plummer, C
Summers, J
Higgins, F
Peacock, J
Harari, D
Bridgewater, J
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2017-02
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
A phase I/II dose finding study evaluating the safety and tolerability of capecitabine and aflibercept in patients with unresectable metastatic colorectal cancer deemed unsuitable for doublet/triplet chemotherapy: results of the phase I study 2017, 72:S69 European Journal of Cancer